Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lineage Cell Therapeutics (LCTX) Construction in Progress: 2014-2019

Historic Construction in Progress for Lineage Cell Therapeutics (LCTX) over the last 2 years, with Mar 2019 value amounting to $8.9 million.

  • Lineage Cell Therapeutics' Construction in Progress was N/A to $8.9 million in Q1 2019 from the same period last year, while for Mar 2019 it was $8.9 million, marking a year-over-year change of. This contributed to the annual value of $1.3 million for FY2018, which is 77.08% down from last year.
  • Latest data reveals that Lineage Cell Therapeutics reported Construction in Progress of $8.9 million as of Q1 2019, which was up 603.31% from $1.3 million recorded in Q4 2018.
  • In the past 5 years, Lineage Cell Therapeutics' Construction in Progress registered a high of $8.9 million during Q1 2019, and its lowest value of $93,000 during Q4 2015.
  • Over the past 3 years, Lineage Cell Therapeutics' median Construction in Progress value was $5.3 million (recorded in 2017), while the average stood at $5.2 million.
  • In the last 5 years, Lineage Cell Therapeutics' Construction in Progress slumped by 77.09% in 2015 and then skyrocketed by 117.26% in 2016.
  • Over the past 5 years, Lineage Cell Therapeutics' Construction in Progress (Quarterly) stood at $93,000 in 2015, then tumbled by 65.25% to $1.6 million in 2016, then reached $5.5 million in 2017, then plummeted by 77.08% to $1.3 million in 2018, then reached $8.9 million in 2019.
  • Its Construction in Progress stands at $8.9 million for Q1 2019, versus $1.3 million for Q4 2018 and $5.1 million for Q3 2018.